When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Mr. Niccol is credited with reviving the burrito chain Chipotle Mexican Grill ( CMG-N +0.86% ) in his last CEO role. He aims ...

While the Dutch company expects to report profits up between 4% and 8% when it releases its full-year 2024 financial results ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

The forecast places the stock at $59.84, representing a 32.07% increase from its current price of $45.31. Numerous factors have contributed to the stock's growth since 2024: By 2026, IonQ’s ...

Let’s breakdown how these predictions are made. Predicting stock prices involves more than just looking at a company’s financials and hoping for the best. Here’s the playbook: Many analysts ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...

Novo Nordisk shares rose Wednesday on the company's home market in Denmark and in the U.S. after UBS analysts upgraded the stock ... Ozempic obesity drugmaker to a "buy," but lowered their price ...

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...